Literature DB >> 3244394

Regulation of adrenergic receptor number following chronic noradrenaline infusion in the rabbit.

N M Deighton1, A D Brown, C A Hamilton, J L Reid.   

Abstract

In order to study noradrenaline-induced regulation of alpha- and beta-adrenoceptors, groups of male New Zealand White rabbits (n = 8) were treated with intravenous noradrenaline (0.09 mumol/kg x h) or ascorbate (0.1%) for 10 days via osmotic minipumps implanted in the femoral vein, and the number of cardiac, lung and lymphocyte beta-adrenoceptors as well as renal and platelet alpha 2-adrenoceptors were determined. 1. The mean arterial blood pressure, heart rate and catecholamine levels were measured before commencing, and after 24 h and 10 days infusion. Circulating noradrenaline concentrations were elevated approximately 6-fold at 24 h and were sustained at these levels after 10 days administration of noradrenaline. There were no significant alterations in the blood pressure while a significant decrease in the heart rate was observed at 24 h. 2. Alpha 2-adrenoceptor density was assessed using [3H]-yohimbine. A significant decrease in the number of alpha 2-adrenoceptors in the kidney was observed following the 10 days infusion with noradrenaline. This down-regulation was in marked contrast to the lack of alteration in platelet alpha 2-adrenoceptor number and the platelet alpha 2-adrenoceptor mediated aggregatory response. 3. The density of beta-adrenoceptors in lymphocytes, heart and lung were quantified using (-)[125I]iodocyanopindolol (ICYP). The noradrenaline infusions caused significant reductions in beta-adrenoceptor number in the heart and lung (containing predominantly beta 1-adrenoceptors) but not in lymphocytes (possessing mainly beta 2-adrenoceptors). The KD-values (pM) for ICYP binding to heart and lung were also significantly decreased in the present studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244394     DOI: 10.1007/bf00179323

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

Review 1.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.

Authors:  T K Harden
Journal:  Pharmacol Rev       Date:  1983-03       Impact factor: 25.468

2.  Adrenoceptors in the diagnosis of phaeochromocytoma.

Authors:  P Valet; C Damase-Michel; B Chamontin; D Durand; G Gaillard; M Salvador; J L Montastruc
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

3.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

4.  Homogeneous class of beta-1 adrenergic receptors in rat kidney. Identification by (+/-)-125 iodocyanopindolol binding.

Authors:  O E Brodde
Journal:  Biochem Pharmacol       Date:  1982-05-01       Impact factor: 5.858

5.  Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.

Authors:  C R Jones; M Giembcyz; C A Hamilton; I W Rodger; K Whyte; N Deighton; H L Elliott; J L Reid
Journal:  Clin Sci (Lond)       Date:  1986-02       Impact factor: 6.124

6.  Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.

Authors:  M A Pfeifer; K Ward; T Malpass; J Stratton; J Halter; M Evans; H Beiter; L A Harker; D Porte
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  Desensitization by noradrenaline of responses to stimulation of pre- and postsynaptic adrenoceptors.

Authors:  N Ball; J L Danks; S Dorudi; P A Nasmyth
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

8.  Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.

Authors:  H Y Chang; R M Klein; G Kunos
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

9.  Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding.

Authors:  O E Brodde; F J Leifert; H J Krehl
Journal:  J Cardiovasc Pharmacol       Date:  1982 Jan-Feb       Impact factor: 3.105

10.  Heterogeneous properties of alpha 2 adrenoceptors in particulate and soluble preparations of human platelet and rat and rabbit kidney.

Authors:  Y D Cheung; D B Barnett; S R Nahorski
Journal:  Biochem Pharmacol       Date:  1986-11-01       Impact factor: 5.858

View more
  4 in total

1.  Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis.

Authors:  A J MacGilchrist; N M Deighton; C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  Effect of a 7-day treatment with idazoxan and its 2-methoxy derivative RX 821002 [correction of RX 821001] on alpha 2-adrenoceptors and non-adrenoceptor idazoxan binding sites in rabbits.

Authors:  M Portillo; M Reverte; D Langin; J M Senard; M A Tran; M Berlan; J L Montastruc
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

3.  Reserpine induces vascular alpha 2-adrenergic supersensitivity and platelet alpha 2-adrenoceptor up-regulation in dog.

Authors:  L Estan; J M Senard; M A Tran; J L Montastruc; M Berlan
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Differential effects of long-term slow-pressor and subpressor angiotensin II on contractile and relaxant reactivity of resistance versus conductance arteries.

Authors:  Phillip G Kopf; Laura E Phelps; Chad D Schupbach; Alan K Johnson; Jacob D Peuler
Journal:  Physiol Rep       Date:  2018-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.